"...M&A, restructuring, capital raising and leading the finance function..."
Take your pick. What is his appointment for? I don't think capital raising is in consideration here as IMU is already very well capitalised. So that left M&A, restructuring and finance function. Given the stage that IMU is at, chances of M&A is rather high, I reckon.
Ann: Imugene appoints experienced life sciences CFO Mike Tonroe, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
-0.010(3.57%) |
Mkt cap ! $78.61M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.0¢ | 27.0¢ | $261.8K | 957.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 262154 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 147810 | 9 |
View Market Depth
| Last trade - 11.32am 30/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |